Chemotherapy-Induced Myelosuppression Treatment Market - Global Industry Analysis
Chemotherapy-Induced Myelosuppression Treatment Market by Indication (Anaemia, Neutropenia and Thrombocytopenia); by Drug Class (Thrombopoietic Agents, Erythropoietin Stimulating Agents, Iron Supplements, Growth Factors and Others); by Route of Administration (Injectable and Oral); By Distribution Channel (Retail Pharmacies, Hospital Pharmacies and Online Pharmacies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025
Published Date: 07-Nov-2019Biotechnology
Category: Report Format : PDF
Report Code: ZMR-5000
Status : Published
Global demand for chemotherapy-induced myelosuppression treatment market was valued at approximately USD 13.81 billion in 2018, and is expected to generate revenue of around USD 17.65 billion by end of 2025, growing at a CAGR of around 3.6% between 2018 and 2025.